These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 19997578)
1. Vascular health in children and adolescents: effects of obesity and diabetes. Short KR; Blackett PR; Gardner AW; Copeland KC Vasc Health Risk Manag; 2009; 5():973-90. PubMed ID: 19997578 [TBL] [Abstract][Full Text] [Related]
2. Lifestyle modification and endothelial function in obese subjects. Hamdy O Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease in childhood: the role of obesity. Herouvi D; Karanasios E; Karayianni C; Karavanaki K Eur J Pediatr; 2013 Jun; 172(6):721-32. PubMed ID: 23340698 [TBL] [Abstract][Full Text] [Related]
4. Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus. Shah AS; Urbina EM Curr Diab Rep; 2017 Jun; 17(6):36. PubMed ID: 28432570 [TBL] [Abstract][Full Text] [Related]
5. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction. Basile J; Houston M; Ferrario CM J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795 [No Abstract] [Full Text] [Related]
6. Endothelial dysfunction and arterial abnormalities in childhood obesity. Skilton MR; Celermajer DS Int J Obes (Lond); 2006 Jul; 30(7):1041-9. PubMed ID: 16801941 [TBL] [Abstract][Full Text] [Related]
14. The endothelium and vascular inflammation in diabetes. Hartge MM; Unger T; Kintscher U Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441 [TBL] [Abstract][Full Text] [Related]
15. [Prevention of cardiovascular disease in type 2 diabetic patients]. Yokota C Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078 [TBL] [Abstract][Full Text] [Related]
16. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes]. Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549 [No Abstract] [Full Text] [Related]
17. Optimal diabetes management during medical weight loss for cardiovascular risk reduction. Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284 [TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Hadi HA; Carr CS; Al Suwaidi J Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104 [TBL] [Abstract][Full Text] [Related]
19. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program. Blonde L; Dempster J; Gallivan JM; Warren-Boulton E J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus. Otsuki M; Goya K; Kasayama S Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]